BullBD Old Apps Site
Home
Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

PHARMAID

All Eps Dividend Board Agm Q1 Q2 Q3

PHARMAID 10-Nov-2021

The Board of Directors has recommended 50% cash dividend for the year ended on June 30, 2021. Date of AGM: 30.12.2021, Time: 11:30 AM, Venue: Digital Platform. Record date: 07.12.2021. The Company has reported EPS of Tk. 16.11, NAV per share of Tk. 93.26 and NOCFPS of Tk. 10.07 for the year ended on June 30, 2021 as against Tk. 16.82, Tk. 82.54 and Tk. 13.04 respectively for the same period of the previous year.

PHARMAID 09-Nov-2021

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 14, 2021 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2021.

PHARMAID 02-Nov-2021

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 09, 2021 at 3:30 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2021.

PHARMAID 07-Oct-2021

The Company has also informed that the Board of Directors of the Company has decided to purchase 1 (one) Annealing Electrical Oven as a replacement of an old Oven for the purpose of reducing wastage and improvement of ampoule quality. Total investment value is expected to be around of BDT 20.00 lac only.

PHARMAID 12-Sep-2021

In response to a DSE query, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike and increase in volume of shares.

PHARMAID 02-May-2021

(Q3 Un-audited): EPS was Tk. 4.12 for January-March 2021 as against Tk. 4.34 for January-March 2020; EPS was Tk. 12.17 for July 2020-March 2021 as against Tk. 14.31 for July 2019-March 2020. NOCFPS was Tk. 9.97 for July 2020-March 2021 as against Tk. 11.94 for July 2019-March 2020. NAV per share was Tk. 89.45 as on March 31, 2021 and Tk. 82.54 as on June 30, 2020. They have informed that EPS decreased due to increase of expenses in connection with COVID-19.

PHARMAID 26-Apr-2021

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 29, 2021 at 2:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2021.

PHARMAID 31-Mar-2021

The Company has informed that they have submitted Dividend Compliance Report as per Regulation-29 of the DSE (Listing) Regulations, 2015 and disbursed the declared dividend accordingly.

PHARMAID 31-Mar-2021

The Company did not send Dividend Compliance Report as per Regulation-29 of the DSE (Listing) Regulations, 2015 in connection with disbursement of the declared dividend. However, DSE has issued query letter to the company for sending the dividend compliance report accordingly.

PHARMAID 31-Jan-2021

(Q2 Un-audited): EPS was Tk. 4.03 for October-December 2020 as against Tk. 5.15 for October-December 2019; EPS was Tk. 8.05 for July-December 2020 as against Tk. 9.77 for July-December 2019. NOCFPS was Tk. 13.89 for July-December 2020 as against Tk. 13.79 for July-December 2019. NAV per share was Tk. 85.41 as on December 31, 2020 and Tk. 82.54 as on June 30, 2020.

Previous Next page